FTY720 protects neuronal cells from damage induced by human prion protein by inactivating the JNK pathway

Moon,Myung-Hee; Jeong,Jae-Kyo; Lee,You-Jin; Park,Sang-Youel

doi:10.3892/ijmm.2013.1528

FTY720 protects neuronal cells from damage induced by human prion protein by inactivating the JNK pathway

Authors:
- Myung-Hee Moon
- Jae-Kyo Jeong
- You-Jin Lee
- Sang-Youel Park
View Affiliations

Affiliations: Biosafety Research Institute, College of Veterinary Medicine, Chonbuk National University, Jeonju, Jeonbuk 561-756, Republic of Korea
Published online on: October 16, 2013 https://doi.org/10.3892/ijmm.2013.1528
Pages: 1387-1393

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Prion diseases affect the central nervous system (CNS) in humans and animals, and are associated with the conversion of the cellular prion protein (PrPC) to the misfolded isoform (PrPSc). FTY720, an immune modulator and synthetic analogue of sphingosine-1-phosphate (S1P), activates S1P receptors and has been shown to be effective in experimental models of transplantation and autoimmunity, including multiple sclerosis. Whereas the immune modulatory functions of FTY720 have been extensively investigated, the other functions of FTY720 are not yet well understood. In this study, we investigated the effects of FTY720 phosphate (FTY720-p) on prion protein-mediated neuronal cell death, as well as its effects on intracellular apoptotic pathways. Treatment with FTY720-p protected neuronal cells from synthetic human prion protein peptide [PrP (106‑126)]-mediated damage and prevented mitochondrial dysfunction by inhibiting the activation of c-jun N-terminal kinase. Moreover, FTY720-p prevented the PrP (106‑126)-induced reduction in mitochondrial potential, the translocation of Bax to the mitochondria and the release of cytochrome c. To the best of our knowledge, this study is the first to demonstrate the effects of FTY720 on prion protein-mediated neurotoxicity and to suggest that FTY720 has therapeutic potential in prion diseases.

View Figures

View References

1	Prusiner SB: Prions. Proc Natl Acad Sci USA. 95:13363–13383. 1998. View Article : Google Scholar : PubMed/NCBI
2	Seo JS, Moon MH, Jeong JK, et al: SIRT1, a histone deacetylase, regulates prion protein-induced neuronal cell death. Neurobiol Aging. 33:1110–1120. 2012. View Article : Google Scholar : PubMed/NCBI
3	Seo JS, Seol JW, Moon MH, Jeong JK, Lee YJ and Park SY: Hypoxia protects neuronal cells from human prion protein fragment-induced apoptosis. J Neurochem. 112:715–722. 2010. View Article : Google Scholar : PubMed/NCBI
4	Watt NT, Taylor DR, Gillott A, Thomas DA, Perera WSS and Hooper NM: Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J Biol Chem. 280:35914–35921. 2005. View Article : Google Scholar
5	Jeong JK, Seo JS, Moon MH, Lee YJ, Seol JW and Park SY: Hypoxia-inducible factor-1 α regulates prion protein expression to protect against neuron cell damage. Neurobiol Aging. 33:1006.e1–10. 2012.
6	Gray F, Chrétien F, Adle-Biassette H, et al: Neuronal apoptosis in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol. 58:321–328. 1999. View Article : Google Scholar : PubMed/NCBI
7	Liberski PP, Sikorska B, Bratosiewicz-Wasik J, Gajdusek DC and Brown P: Neuronal cell death in transmissible spongiform encephalopathies (prion diseases) revisited: from apoptosis to autophagy. Int J Biochem Cell Biol. 36:2473–2490. 2004. View Article : Google Scholar : PubMed/NCBI
8	Forloni G, Angeretti N, Chiesa R, et al: Neurotoxicity of a prion protein fragment. Nature. 362:543–546. 1993. View Article : Google Scholar : PubMed/NCBI
9	Brown DR, Schmidt B and Kretzschmar HA: Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature. 380:345–347. 1996. View Article : Google Scholar : PubMed/NCBI
10	Florio T, Thellung S, Amico C, et al: Prion protein fragment 106-126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell line. J Neurosc Res. 54:341–352. 1998. View Article : Google Scholar : PubMed/NCBI
11	Ettaiche M, Pichot R, Vincent J-P and Chabry J: In vivo cytotoxicity of the prion protein fragment 106-126. J Biol Chem. 275:36487–36490. 2000. View Article : Google Scholar : PubMed/NCBI
12	Jeong JK, Moon MH, Lee YJ, Seol JW and Park SY: Autophagy induced by the class III histone deacetylase Sirt1 prevents prion peptide neurotoxicity. Neurobiol Aging. 34:146–156. 2013. View Article : Google Scholar : PubMed/NCBI
13	O’Donovan CN, Tobin D and Cotter TG: Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY₅Y cells. J Biol Chem. 276:43516–43523. 2001.PubMed/NCBI
14	Kiuchi M, Adachi K, Kohara T, et al: Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols. J Med Chem. 43:2946–2961. 2000. View Article : Google Scholar : PubMed/NCBI
15	Wei Y, Yemisci M, Kim HH, et al: Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol. 69:119–129. 2011. View Article : Google Scholar : PubMed/NCBI
16	Kihara A and Igarashi Y: Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720. Biochim Biophys Acta. 1781:496–502. 2008. View Article : Google Scholar : PubMed/NCBI
17	Stessin AM, Gursel DB, Schwartz A, et al: FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells. Neurosci Lett. 516:253–258. 2012. View Article : Google Scholar
18	Miron VE, Schubart A and Antel JP: Central nervous system-directed effects of FTY720 (fingolimod). J Neurol Sci. 274:13–17. 2008. View Article : Google Scholar : PubMed/NCBI
19	Harada J, Foley M, Moskowitz MA and Waeber C: Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells. J Neurochem. 88:1026–1039. 2004. View Article : Google Scholar : PubMed/NCBI
20	Chun J, Weiner JA, Fukushima N, et al: Neurobiology of receptor-mediated lysophospholipid signaling. From the first lysophospholipid receptor to roles in nervous system function and development. Ann N Y Acad Sci. 905:110–117. 2000. View Article : Google Scholar
21	Edsall LC, Pirianov GG and Spiegel S: Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. J Neurosci. 17:6952–6960. 1997.PubMed/NCBI
22	Jackson SJ, Giovannoni G and Baker D: Fingolimod modulates microglial activation to augment markers of remyelination. J Neuroinflammation. 8:762011. View Article : Google Scholar : PubMed/NCBI
23	Deogracias R, Klein C, Matsumoto T, et al: Expression of brain-derived neurotrophic factor is regulated by fingolimod (FTY720) in cultured neurons. Mult Scler. 14:S2432008.
24	Brinkmann V, Cyster JG and Hla T: FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant. 4:1019–1025. 2004. View Article : Google Scholar : PubMed/NCBI
25	Valentine WJ, Kiss GN, Liu J, et al: (S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity. Cell Signal. 22:1543–1553. 2010. View Article : Google Scholar : PubMed/NCBI
26	Tournier C, Hess P, Yang DD, et al: Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science. 288:870–874. 2000. View Article : Google Scholar : PubMed/NCBI
27	Tsuruta F, Sunayama J, Mori Y, et al: JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J. 23:1889–1899. 2004. View Article : Google Scholar : PubMed/NCBI
28	Ehling R, Berger T and Reindl M: Multiple sclerosis - established and novel therapeutic approaches. Cent Nerv Syst Agents Med Chem. 10:3–15. 2010. View Article : Google Scholar : PubMed/NCBI
29	Gonzalez-Cabrera PJ, Cahalan SM, Nguyen N, et al: S1P(1) receptor modulation with cyclical recovery from lymphopenia ameliorates mouse model of multiple sclerosis. Mol Pharmacol. 81:166–174. 2012.
30	Kim HJ, Miron VE, Dukala D, et al: Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model. FASEB J. 25:1509–1518. 2011. View Article : Google Scholar : PubMed/NCBI
31	Lin MT and Beal MF: Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 443:787–795. 2006. View Article : Google Scholar : PubMed/NCBI
32	Jeong JK, Moon MH, Lee YJ, Seol JW and Park SY: Melatonin-induced autophagy protects against human prion protein-mediated neurotoxicity. J Pineal Res. 53:138–146. 2012. View Article : Google Scholar : PubMed/NCBI
33	Schroeter H, Boyd CS, Ahmed R, et al: c-Jun N-terminal kinase (JNK)-mediated modulation of brain mitochondria function: new target proteins for JNK signalling in mitochondrion-dependent apoptosis. Biochem J. 372:359–369. 2003. View Article : Google Scholar